NASD · Healthcare · Healthcare Plans · USA
Clover Health Investments Corp is a mid cap company (market value between $2 billion and $10 billion) in the Healthcare Plans industry.
Clover Health Investments Corp provides Medicare Advantage insurance coverage across multiple states, primarily through PPO and HMO plans offering members low co-payment rates for primary and specialist care. The company operates a proprietary software platform called Clover Assistant that aggregates clinical data to deliver personalized treatment recommendations to physicians, enabling earlier identification and management of chronic diseases.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Clover Health Investments Corp stock.
Undervalued: intrinsic value $13.38 per share, market price $4.44, margin of safety 66.8% (as of 2026-10-19).
A 2.8x revenue multiple, discounted for its losses, values the shares at $13.38; the price of $4.44 is 67% below that value.
Leak Score: 53/100 on 8 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 11 Healthcare Plans stocks
CLOV is undervalued (as of the 2026-10-19 close). A 2.8x revenue multiple, discounted for its losses, values the shares at $13.38; the price of $4.44 is 67% below that value.
$13.38 per share (as of the 2026-10-19 close), against a market price of $4.44. That is a margin of safety of 66.8%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
53 out of 100, which we rate "Weak Signal", on 8 of 12 value investing signals.